Dementia
-
Researchers urge caution around breakthrough Alzheimer’s drug
Posted on:
As we live longer and there are more people living into old age, there is an increasing number of people developing dementia with more than 400,000 people currently living with the condition in Australia. Dementia is now the leading cause of death in Australia, and Alzheimer’s disease is the most common cause of dementia. Dementia
Category:
-
Clinical trials informed by patient care
Posted on:
The Kolling Institute’s Professor Sue Kurrle and her team at the Rehabilitation and Aged Care Network at Hornsby Ku-ring-gai Hospital have been running clinical trials for 25 years, looking at dementia, frailty, and falls to name just some areas. “We do trials as it keeps you cutting edge and they are really important for our
-
Kolling NEWS
Posted on:
Our Kolling Institute newsletter brings together a collection of profiles on our impressive researchers. Flip through our flipping book to discover more about our leading research into kidney disease, rare cancers and the use of supplements for osteoarthritis. There’s a focus too on the first steps towards gene therapy for Meniere’s disease, the latest research into treatments for
-
Kolling researchers receive Australia Day honours
Posted on:
Two of our outstanding Kolling Institute researchers have been recognised in this year’s Australia Day honours roll. Professor Sue Kurrle has been appointed an Officer of the Order of Australia (AO) for distinguished service to medicine as a geriatrician, and to research into dementia and cognitive decline. Sue works at Hornsby Ku-ring-gai and Batemans Bay
-
Recognition for research excellence
Posted on:
Congratulations to Professor David Hunter who’s received a prestigious University of Sydney Vice Chancellor’s award for outstanding research. The Kolling researcher and rheumatology clinician is regarded as the world’s leading expert in osteoarthritis. Professor Hunter’s research has had a significant and lasting impact in the field of osteoarthritis, influencing clinical practice and access to evidence-based
-
Northern Sydney leading the way with arthritis research and clinical care
Posted on:
The latest exciting research into musculoskeletal disease has been unveiled during the inaugural Northern Lights showcase. Close to 200 people attended the jam packed event in the Kolling auditorium, including clinicians, researchers and many people living with arthritic pain. RNSH Head of Rheumatology Professor Lyn March addressed the event, detailing the devastating cost of the
Category:
Copyright © 2026 Kolling Institute
All rights reserved